Efficacy and Safety of Low-dose Ticagrelor

NCT03381742 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

3043

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Ticagrelor
DRUG: ticagrelor
DRUG: ticagrelor
DRUG: clopidogrel

Sponsor

First Affiliated Hospital of Harbin Medical University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]